Search Login Register

Hemangiosarcoma (Angiosarcoma) Summary

Description: A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)

Also Known As: Angiosarcoma; Angiosarcomas; Hemangiosarcomas

Networked: 1588 relevant articles (68 outcomes, 111 trials/studies) for this Disease

Key Drugs and Agents for Hemangiosarcoma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Doxorubicin (Adriamycin) : 10 outcomes 3 studies in 50 results : FDA 12 Generic
  2. docetaxel (Taxotere) : 7 outcomes 2 studies in 27 results : FDA 3
  3. Paclitaxel (Taxol) : 5 outcomes 7 studies in 38 results : FDA 13 Generic
  4. Interleukin-2 (IL2) : 4 outcomes in 18 results : IBA
  5. taxane : 3 outcomes 2 studies in 9 results : IBA
  6. Ifosfamide : 3 outcomes 1 study in 12 results : FDA 7 Generic
  7. gemcitabine : 2 outcomes 2 studies in 13 results : FDA 7
  8. bevacizumab : 2 outcomes 2 studies in 10 results : FDA 2
  9. 1-dodecylpyridoxal (PLD) : 2 outcomes 1 study in 2 results : IBA
  10. Taxoids : 2 outcomes in 11 results : IBA
Show All >>

Diseases Related to Hemangiosarcoma

  1. Neoplasms (Cancer)
  2. Sarcoma (Soft Tissue Sarcoma)
  3. Liposarcoma
  4. Melanoma (Melanoma, Malignant)
  5. Hemangioma (Angioma)
Show All >>

Key Therapies for Hemangiosarcoma

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 10 outcomes 4 studies in 125 results
  2. Radiotherapy : 10 outcomes 3 studies in 159 results
  3. Adjuvant Chemotherapy : 3 outcomes in 13 results
  4. Aftercare (After-Treatment) : 2 outcomes 1 study in 19 results
  5. Splenectomy : 2 outcomes in 25 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.